Director/PDMR Shareholding

Indivior

17/03/2025 13:25

RNS Number : 9775A

Indivior PLC

17 March 2025

 

INDIVIOR PLC (THE 'COMPANY')

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES ('PDMR') AND PERSONS CLOSELY ASSOCIATED WITH THEM

The Company announces the following changes to interests of persons discharging managerial responsibilities ('PDMR') in the Ordinary Shares of $0.50 each in the Company ('Shares').

On March 17, 2025, in accordance with the Rules of the Deferred Bonus Plan 2018 (the 'DBP'), awards granted on March 16, 2023 vested following the end of the two-year deferral period for the two PDMRs named below. The vesting of the award was not subject to performance conditions.  The vesting of this award was settled on a net settled basis, resulting in the delivery of Shares in the amount set out below.

Name
Position
Number of vested Shares
Number of Shares delivered
Mark Crossley
Director/PDMR - Chief Executive Officer
18,169
9,974
Ryan Preblick
PDMR - Chief Financial Officer
6,572
4,361

 

Following these transactions, Mark Crossley has an interest in 350,927 Shares in the Company and Ryan Preblick has an interest in 72,747 Shares in the Company.

This notification is made in accordance with the requirements of the UK Market Abuse Regulation.

Kathryn Hudson

Company Secretary

1
Details of the person discharging managerial responsibilities / person closely associated
a)
Name
Mark Crossley
2
Reason for the notification
a)
Position/status
Director / PDMR - Chief Executive Officer
b)
Initial notification /Amendment
Initial notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Indivior PLC
b)
LEI
213800V3NCQTY7IED471
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Identification code
Ordinary Shares of US$0.50
GB00BN4HT335
b)
Nature of the transaction
Delivery of Shares on Vesting of an award granted under the DBP.
c)
Price(s) and volume(s)
Price(s)
Volume(s)
N/A
9,974
d)
Aggregated information
- Aggregated volume
- Price
N/A
e)
Date of the transaction
March 17, 2025
f)
Place of the transaction
Outside a trading venue
1
Details of the person discharging managerial responsibilities / person closely associated
a)
Name
Ryan Preblick
2
Reason for the notification
a)
Position/status
Director / PDMR - Chief Financial Officer
b)
Initial notification /Amendment
Initial notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Indivior PLC
b)
LEI
213800V3NCQTY7IED471
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Identification code
Ordinary Shares of US$0.50
GB00BN4HT335
b)
Nature of the transaction
Delivery of Shares on Vesting of an award granted under the DBP.
c)
Price(s) and volume(s)
Price(s)
Volume(s)
N/A
4,361
d)
Aggregated information
- Aggregated volume
- Price
N/A
e)
Date of the transaction
March 17, 2025
f)
Place of the transaction
Outside a trading venue

 

Indivior PLC's Legal Entity Identifier code is 213800V3NCQTY7IED471.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 
  END

 

 
DSHGPUPPWUPAGWM